Clinical Trials Logo

Clinical Trial Summary

Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality of life, lacking effective treatment options or systematic clinical evidence to support a therapy. The primary objective of this clinical trial is to evaluate the safety and effectiveness of a hybrid sinus node sparing ablation procedure for the treatment of symptomatic drug refractory or drug intolerant IST.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05280093
Study type Interventional
Source AtriCure, Inc.
Contact Joseph Derr
Phone 1 (866) 349-2342
Email jderr@atricure.com
Status Recruiting
Phase N/A
Start date May 31, 2022
Completion date June 2027

See also
  Status Clinical Trial Phase
Completed NCT01657136 - Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia Phase 3
Recruiting NCT03317249 - Pregnancy Related Inappropriate Sinus Tachycardia
Recruiting NCT05107635 - Inappropriate Sinus Tachycardia Registry
Recruiting NCT02018497 - Essential Hypotension and Allostasis Registry
Withdrawn NCT01695538 - Yoga and Rate and Duration of Inappropriate Sinus Tachycardia (IST) Episodes N/A
Terminated NCT00584649 - Ablation of Inappropriate Sinus Tachycardia N/A